Picture of Memphasys logo

MEM — Memphasys News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Australia's Memphasys surges on exclusive deal with Qatar co

** Memphasys MEM.AX surges as much as 71.4% to A$0.006; set for strongest session since August 18, 2022

** Stock hits highest since June 30

** Medical devices maker signs exclusive master distribution agreement with Qatar-based International Technical Legacy (ITL), which specialises in IVF services

** Deal grants ITL exclusive commercial, distribution rights for Felix male fertility sperm preparation system across 15 countries in Middle East and North Africa (MENA)

** Co says ITL will place initial binding order for Felix cartridges valued at A$325,000 ($213,135)

** About 16 million shares traded, 10.3x the 30-day avg

** YTD, MEM falls 25%

($1 = A$1.5249)

 (Reporting by Ananya Verma in Bengaluru)

 ((ananya.verma@thomsonreuters.com;))

Recent news on Memphasys

See all news